Vaxart, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Vaxart, Inc. (VXRT) reported Adjustments to Additional Paid in Capital, Warrant Issued of $333.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2021-02-25
- Vaxart, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was $333.00K.
- Vaxart, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-03-31 was $100.00K, a 42.86% increase year-over-year.
- Vaxart, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- Vaxart, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $0.00.
- Vaxart, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $70.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2019-06-30 | $333.00K 10-Q · filed 2019-08-08 | $433.00K derived: sum of 2 quarters · filed 2019-08-08 | $433.00K derived: sum of 3 quarters · filed 2021-02-25 | $433.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $100.00K 10-Q · filed 2019-08-08 | $100.00K derived: sum of 2 quarters · filed 2021-02-25 | $100.00K derived: sum of 3 quarters · filed 2021-02-25 | $100.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $70.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $70.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $70.00K 10-Q · filed 2018-08-10 | ||
| 2018-03-31 | $70.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |